AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-78804992/zometa-oked-one-indication.html" title="Facts and information about Zometa OK'ed for one indication, Novartis tries for another.(Brief Article)">Zometa OK'ed for one indication, Novartis tries for another.(Brief Article)</a>

Close Set up an RSS feed that alerts you when new articles from Drug Store News are available.

Frequently asked questions about RSS feeds

Zometa OK'ed for one indication, Novartis tries for another.(Brief Article)

Drug Store News

| September 24, 2001 | COPYRIGHT 1989 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Days after Novartis received FDA approval to market Zometa (zoledronic acid for injection) as a hypercalcemia treatment, the drug company filed an additional indication for the drug. Novartis was cleared to market Zometa Aug. 20 for the treatment of hypercalcemia, a potentially deadly release of excess calcium m the blood of cancer patients caused by the breakdown of bone. It has a shorter administration time than the leading treatment, Aredia (pamidronate disoudium for injection), taking only 15 minutes compared with two hours to 24 hours.

Days after the first…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


ZOMETA(R) (zoledronic acid for injection) Significantly Reduced Risk Of Bone...: Press release article from: PR Newswire December 11, 2002 700+ words
...Fractures and Other Cancer-related Bone Complications with ZOMETA ZOMETA(R) (zoledronic acid for injection) significantly...compression and hypercalcemia. An intravenous bisphosphonate, ZOMETA is the first therapy of its kind to demonstrate efficacy...


ZOMETA(R) Significantly Increased Bone Mineral Density in Men Receiving...: Press release article from: PR Newswire May 23, 2003 700+ words
Treatment with ZOMETA(R) (zoledronic acid) Injection significantly...in Journal of Urology demonstrated that ZOMETA treatment not only prevented treatment...American men. "The data indicating that ZOMETA increases bone density in prostate cancer...


Zometa reduces risk of breast cancer recurrence in premenopausal women, study...: News wire article from: Europe Intelligence Wire February 11, 2009 700+ words
...Adding Zometa to post-surgery hormone therapy reduced risk of breast...First Phase III data to substantiate anticancer effect of Zometa Zometa is the most widely prescribed drug for prevention of...


Novartis' ZOMETA(R)(zoledronic acid for injection) - A Major Advance in the...: Press release article from: PR Newswire October 3, 2002 700+ words
ZOMETA data published in the Journal of the National...complications which result from prostate cancer ZOMETA(R) (zoledronic acid for injection...National Cancer Institute. In the study, Zometa was infused at a dose of 4 mg given over...


Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal...: Press release article from: PR Newswire February 11, 2009 700+ words
- Adding Zometa to post-surgery hormone therapy reduced risk of breast cancer return...therapy alone - First Phase III data to substantiate anticancer effect of Zometa - Zometa is the most widely prescribed drug for prevention of bone complications...


New Data Show Zometa(R) Enhances Impact of Chemotherapy on Reducing Breast...: Press release article from: PR Newswire December 11, 2008 700+ words
-- Adding Zometa to chemotherapy prior to surgery led to an additional...New data are first to demonstrate direct effect of Zometa to help shrink primary tumors; further evidence of Zometa as a potential EAST HANOVER, N.J., Dec. 11...


New Data Show Zometa(R) Reduces Bone Loss in Patients Receiving Breast Cancer...: Press release article from: PR Newswire Europe May 16, 2005 700+ words
...in Orlando, Florida, demonstrate that Zometa(R) (zoledronic acid), an intravenous...loss. This new data from the Z-FAST (Zometa-Femara Adjuvant Synergy Trial) study offers evidence that Zometa may prevent bone loss in these patients...


New data show Zometa enhances impact of chemotherapy on reducing breast tumor...: News wire article from: Europe Intelligence Wire December 11, 2008 700+ words
...Adding Zometa to chemotherapy prior to surgery led to...are first to demonstrate direct effect of Zometa to help shrink primary tumors; further evidence of Zometa as a potential anticancer therapy Basel...


New data show Zometa[R] significantly improved bone mineral density in breast...: News wire article from: Europe Intelligence Wire May 15, 2005 700+ words
...aromatase inhibitors Basel, May 16, 2005 - Zometa[R] (zoledronic acid), an intravenous...patients treated with Femara and upfront Zometa compared with those who received Femara and delayed Zometa. These data were presented at the American...


FDA Approves Novartis Drug ZOMETA(R) (zoledronic acid for injection) for the...: Press release article from: PR Newswire February 22, 2002 700+ words
...FDA) today approved the Novartis drug ZOMETA(R) (zoledronic acid for injection...The trials that led to the approval of ZOMETA mark the first time any bisphosphonate...cancer and other solid tumors. Further, ZOMETA offers patients, nurses and clinicians...

For more facts and information, see all results

The AccessMyLibrary advertising network includes: